☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
Pracinostat
Helsinn and MEI Terminate its P-III Study of Pracinostat for Patients with AML
July 3, 2020
Helsinn Enters into an Exclusive Distribution and License Agreement with Blanver and Varifarma for Pracinostat in South America
September 3, 2019
Load more...
Back to Home
